Adaptive Biotechnologies (ADPT) Short term Debt (2023 - 2026)

Adaptive Biotechnologies (ADPT) has 4 years of Short term Debt data on file, last reported at $5.8 million in Q1 2026.

• Quarterly Short term Debt rose 188.61% year-over-year to $5.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.8 million (up 188.61% YoY) and the FY2025 annual result came in at $4.6 million, up 436.65% from the prior year.
• Short term Debt climbed to $5.8 million in Q1 2026 per ADPT's latest filing, from $4.6 million in the prior quarter.
• The five-year high for Short term Debt was $5.8 million in Q1 2026, with the low at $865000.0 in Q4 2024.
• Average Short term Debt over 4 years is $3.1 million, with a median of $3.1 million recorded in 2025.
• Year-over-year, Short term Debt jumped 436.65% in 2025 and jumped 188.61% in 2026.
• Adaptive Biotechnologies' Short term Debt stood at $3.2 million in 2023, then sank by 72.92% to $865000.0 in 2024, then jumped by 436.65% to $4.6 million in 2025, then advanced by 25.03% to $5.8 million in 2026.
• Business Quant data shows ADPT's Short term Debt at $5.8 million in Q1 2026, $4.6 million in Q4 2025, and $2.4 million in Q3 2025.